Effects of glucosamine derivatives and uronic acids on the production of glycosaminoglycans by human synovial cells and chondrocytes

International Journal of Molecular Medicine

Volumn 27, Issue 6, 2011, Pages 821-827

  Igarashi, Mamoru ^a   Kaga, Izuho ^b   Takamori, Yoshomori ^b   Sakamoto, Koji ^b   Miyazawa, Keiji ^c   Nagaoka, Isao ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b Koyo Chemical Co Ltd   (Japan)

^c KISSEI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Chondrocytes; Glucosamine; Glycosaminoglycan; Hyaluronic acid; Synovial cells; Uronic acid

Indexed keywords

GALACTURONIC ACID; GLUCOSAMINE DERIVATIVE; GLUCURONIC ACID; GLYCOSAMINOGLYCAN; HYALURONAN SYNTHASE; HYALURONIC ACID; KERATAN SULFATE; SYNTHETASE; UNCLASSIFIED DRUG; URONIC ACID;

ARTICLE; CARTILAGE CELL; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNOVIAL FLUID; SYNOVIUM; UPREGULATION;

CHONDROCYTES; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSAMINE; GLYCOSAMINOGLYCANS; HUMANS; SYNOVIAL FLUID; URONIC ACIDS;

EID: 79954554877     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.662     Document Type: Article

References (25)

1. Gabriel SE, Crowson CS, Campion ME and O'Fallon WM: Direct medical costs unique to people with arthritis. J Rheumatol 24: 719-725, 1997. (Pubitemid 27146091)
2. March LM and Bachmeier CJ: Economics of osteoarthritis: a global perspective. Baillieres Clin Rheumatol 11: 817-834, 1997.
3. Martel-Pelletier J, Lajeunesse D and Pelletier JP: Etiopathogenesis of osteoarthritis. In: Arthritis and Allied Conditions: A Textbook of Rheumatology. 15th edition. Koopman WT and Moreland LW (eds.) Lippincott Williams & Wilkins, Philadelphia, Vol. 2, pp2199-2226, 2005.
4. Puhl W, Bernau A, Greiling H, Köpeke W, Pförringer W, Steck KJ, Zacher J and Scharf HP: Intra-articular sodium hyaluronate in osteoarthritis of the knee: a multicenter, double-blind study. Osteoarthritis Cartilage 1: 233-241, 1993.
5. Buckwalter JA and Mankin IIJ: Articular cartilage: degeneration and osteoarthritis, repair, regeneration, and transplantation. Instr Course Lect 47: 487-504, 1998.
6. Grolle G and D'Este E: Glucosamine sulphate for the management of arthrosis: a controlled clinical investigation. Curr Med Res Opin 7: 104-109, 1980.
7. Drovanti A, Bignamini AA and Rovati AL: Therapeutic activity of oral glucosamine sulfate in osteoarthrosis: a placebo-controlled double-blind investigation. Clin Ther 3: 260-272, 1980. (Pubitemid 11122261)
8. Tapadinhas MJ, Rivera IC and Bignamini AA: Oral glucosamine sulphate in the management of arthrosis: report on a multi-centre open investigation in Portugal. Pharmatherapeutica 3: 157-168, 1982. (Pubitemid 13242759)
9. Lopes VA: Double-blind clinical evaluation of the relative efficacy of ibuprofen and glucosamine sulphate in the management of ostearthrosis of the knee in out-patients. Curr Med Res Opin 8: 145-149, 1982.
10. McAlindon TE, LaValley MP, Gulin JP and Felson DT: Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA 283: 1469-1475, 2000. (Pubitemid 30151826)
11. Reginster JY, Deroisy R, Rovati LC, Lee RL, Lejeune E, Bruyene O, Giacovelli G, Henrotin Y, Dacre JE and Gossett C: Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet 357: 251-256, 2001. (Pubitemid 32120855)
12. Pavelka K, Gatterova J, Olejarova M, Machacek S, Giacovelli G and Rovati LC: Glucosamine sulfate use and delay of progression of knee osteoarthrisis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med 162: 2113-2123, 2002. (Pubitemid 35168220)
13. Zhang W, Moskowitz RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS and Tugwell P: OARSI recommendations for the managemant of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 16: 137-162, 2008. (Pubitemid 351222155)
14. Hua J, Sakamoto K, Kikukawa T, Abe C, Kurosawa H and Nagaoka I: Evaluation of the suppressive actions of glucosamine on the interleukin-1β- mediated activation of synoviocytes. Inflamm Res 56: 432-438, 2007. (Pubitemid 350160419)
15. Yielding KL, Tomkins GM and Bunim JJ: Synthesis of hyaluronic acid by human synovial tissue slices. Science 125: 1300, 1957.
16. Kollker SJ, Walder RY, Usachev Y, Hillman J, Boyle DL, Firestein GS and Sluka KA: Acid-sensing ion channel 3 expressed in type B synoviocytes and chondrocytes modulates hyaluronan expression and release. Ann Rheum Dis 69: 903-909, 2010.
17. Iwasa J, Ochi M, Uchio Y, Katsube K, Adachi N and Kawasaki K: Effects of cell density on proliferation and matrix synthesis of chondrocytes embedded in atelocollagen gel. Artif Organs 27: 249-255, 2003. (Pubitemid 36423481)
18. Carrino DA and Caplan AI: Isolation and characterization of proteoglycans synthesized in ovo by embryonic chick cartilage and new bone. J Biol Chem 260: 122-127, 1985. (Pubitemid 15165290)
19. Bastow ER, Byers S, Golub SB, Clarkin CE, Pitsillides AA and Fosang AJ: Hyaluronan synthesis and degradation in cartilage and bone. Cell Mol Life Sci 65: 395-413, 2008. (Pubitemid 351214652)
20. Miyazawa K, Mori A and Okudera H: Establishment and characterization of a novel human rheumatoid fibroblast-like synoviocyte line, MH7A, immortalized with SV40 Tantigen. J Biochem 124: 1153-1162, 1998. (Pubitemid 29017304)
21. Evanko SP and Wight TN: Intracellular localization of hyaluronan in proliferating cells. J Histochem Cytochem 47: 1331-1341, 1999. (Pubitemid 29455929)
22. Tammi R, Rilla K, Pienimâki J-P, MacCallum DK, Hogg M, Luukkonen M, Hascall VC and Tammi M: Hyaluronan enters keratinocytes by a novel endocytic route for catabolism. J Biol Chem 276: 35111-35122, 2001.
23. Belcher C, Yaqub R, Fawthrop F, Bayliss M and Doherty M: Synovial fluid chondroitin and keratan sulphate epitopes, glycosaminoglycans, and hyaluronan in arthritic and normal knees. Ann Rheum Dis 56: 299-307, 1997. (Pubitemid 27278517)
24. Divine JG, Zazulak BT and Hewett TE: Viscosupplementation for knee osteoarthritis. Clin Orthop Relat Res 455: 113-122, 2006.
25. Nakayama Y, Shiraki Y, Yoshihara K and Uesaka S: Evaluation of glycosaminoglycans levels in normal joint fluid of the knee. J Nippon Med Sch 67: 92-95, 2000.